Gartisertib

DB18770InvestigationalSmall molecule

Gartisertib: Overview.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase ATR
Curator reviewed
Formula / weight: C₂₅H₂₉F₂N₉O₃ · 541.564 g/mol (avg)
Code names: M-4344 · VX-803

Resolves to

Compound

Structure

InChIKeyQAYHKBLKSXWOEO-UHFFFAOYSA-NSMILESNC1=NN2C=C(F)C=NC2=C1C(=O)NC1=CN=CC(F)=C1N1CCC(CC1)C(=O)N1CCN(CC1)C1COC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gartisertib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.